All News

Switching Tasigna elicited a long-term response rate in patients with leukemia even after discontinuing treatment.

Switching from Glivec to Tasigna elicited a long-term response rate in patients with leukemia.

Lenalidomide (Revlimid) could potentially offer clinical benefits to patients with multiple myeloma.

Lenalidomide (Revlimid) could potentially offer clinical benefits to patients with multiple myeloma.

A newly created tool can diagnose cachexia in patients with cancer and other diseases.

Interim findings further support the efficacy, safety, and tolerability of Abraxane in NSCLC.

Abraxane shows promise in hard-to-treat non-small cell lung cancer patients.

Take a minute to watch and share with your patients, if only for the cute pictures of kittens and puppies.

Some atopic dermatitis patients at risk for developing contact dermatitis from certain common ingredients in topical products.

Some atopic dermatitis patients at risk for developing contact dermatitis from certain common ingredients in topical products.

Managing fatigue is a significant burden in multiple sclerosis.

Top news of the day from across the healthcare landscape.

Sitagliptin (Januvia/Merck) helps manage diabetes patients admitted hospital for general medical problems or surgery.

Top news of the day from across the health care landscape.

AcelRX has submitted a New Drug Application (NDA) to the FDA for ARX-04 (sufentanil tablets).

Falls can cause significant mortality and morbidity in the aging population.

A PGY-2 Oncology Residency Director shares her advice for residents about remaining adaptable.

The United States Pharmacopeial Convention (USP) has published a quality standard for chlorhexidine gel, an antiseptic used to prevent life-threatening umbilical cord infections in newborns

Pioglitazone may increase a patient’s risk of developing bladder cancer.

Pioglitazone may increase a patient’s risk of developing bladder cancer.

The National Association of Chain Drug Stores (NACDS) is strategically advancing its highly effective, results-driven government affairs and public policy team by announcing the selection of William Tighe as vice president of federal government affairs and Amber Manko as director of federal government affairs.

Results from an interim analysis show ritixumab biosimilar to be equivalent to reference product.

Pharmacists must adjust their counseling approaches as more treatment options become available for patients with cancer.

The biggest spender doesn’t always come out ahead in the world of specialty medications.

Individuals with a history of cigarette smoking may benefit from regular ibuprofen use.

Modified kidney cells could potentially regulate insulin for 3 weeks in patients with diabetes.

A new study examines a different treatment strategy for pneumonia.

The proportion of specific inflammatory proteins can influence treatment outcomes.

Top news of the day from across the health care landscape.